FDA Announces Approval of Waiver-Related Materials for Postmarket Safety Reports

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on providing postmarket periodic safety reports in the International Conference on Harmonisation E2C(R2) format, as outlined in draft guidance for the industry.